Published in BMJ on June 29, 2002
Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ (2005) 2.12
The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med (2012) 1.22
Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. BMJ (2003) 0.92
Respiratory medicine. Br J Gen Pract (2004) 0.92
Management of asthma in adults: current therapy and future directions. Postgrad Med J (2003) 0.88
A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics. Br J Clin Pharmacol (2003) 0.86
Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review. Respir Res (2004) 0.86
The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med (2016) 0.85
Montelukast in asthma: a review of its efficacy and place in therapy. Ther Adv Chronic Dis (2011) 0.83
Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res (2014) 0.82
Leukotriene-Receptor Antagonists Versus Placebo in the Treatment of Asthma in Adults and Adolescents: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 0.77
Introduction of leukotriene receptor antagonists in Manitoba. Can Respir J (2006) 0.76
The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1. Open Access Maced J Med Sci (2015) 0.75
2003 canadian asthma consensus guidelines executive summary. Allergy Asthma Clin Immunol (2006) 0.75
In children with asthma who are currently using inhaled corticosteroids, are antileukotrienes more effective than placebo in improving clinical outcomes?: Part A. Paediatr Child Health (2003) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Estimation of a common effect parameter from sparse follow-up data. Biometrics (1985) 5.40
Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol (2000) 3.70
Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. J Pediatr (2001) 2.17
Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med (1999) 1.50
Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med (2000) 1.20
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. Am J Respir Crit Care Med (1997) 1.15
The role of glucocorticoids in the management of asthma. Allergy Asthma Proc (1997) 0.99
Leukotrienes and the airways. Eur J Anaesthesiol (1989) 0.84
[Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics]. Arerugi (1999) 0.82